Management of portal hypertensive gastropathy and other bleeding.
- Author:
Woo Jin CHUNG
1
Author Information
- Publication Type:Review
- Keywords: Gastric antral vascular ectasia; Liver cirrhosis; Portal hypertensive gastropathy
- MeSH: Gastric Antral Vascular Ectasia/complications; Gastric Mucosa/pathology; Gastrointestinal Hemorrhage/*etiology; Humans; Hypertension, Portal/*complications/prevention & control; Liver Cirrhosis/complications; Peptic Ulcer/complications
- From:Clinical and Molecular Hepatology 2014;20(1):1-5
- CountryRepublic of Korea
- Language:English
- Abstract: A major cause of cirrhosis related morbidity and mortality is the development of variceal bleeding, a direct consequence of portal hypertension. Less common causes of gastrointestinal bleeding are peptic ulcers, malignancy, angiodysplasia, etc. Upper gastrointestinal bleeding has been classified according to the presence of a variceal or non-variceal bleeding. Although non-variceal gastrointestinal bleeding is not common in cirrhotic patients, gastroduodenal ulcers may develop as often as non-cirrhotic patients. Ulcers in cirrhotic patients may be more severe and less frequently associated with chronic intake of non-steroidal anti-inflammatory drugs, and may require more frequently endoscopic treatment. Portal hypertensive gastropathy (PHG) refers to changes in the mucosa of the stomach in patients with portal hypertension. Patients with portal hypertension may experience bleeding from the stomach, and pharmacologic or radiologic interventional procedure may be useful in preventing re-bleeding from PHG. Gastric antral vascular ectasia (GAVE) seems to be different disease entity from PHG, and endoscopic ablation can be the first-line treatment.
